Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3489618 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL3489337 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL12664499 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL2844102 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL3487958 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL2838700 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL22539912 | 0.96 | ALDH1A1 (0.45) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL28527696 | 0.96 | ALDH1A1 (0.45) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL3262466 | 0.96 | ALDH1A1 (0.47) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL3262460 | 0.96 | ALDH1A1 (0.47) | ALDH1A1CNR1CNR2LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2388 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235559-A1 | GENE EDITING REPORTER SYSTEM AND GUIDE RNA AND COMPOSITION RELATED THERETO; COMPOSITION AND METHOD FOR KNOCKING OUT DNA WITH MORE THAN TWO GRNAS; GENE EDITING IN THE EYE; AND GENE EDITING USING BASE EDITORS | Incisive Genetics Inc. (CA) | 2025-07-24 | — | — | US | claimed |
| WO-2025103414-A1 | PREPARATION METHOD FOR AND USE OF LIPID NANOPARTICLES | 上海瑞宏迪医药有限公司 | 2025-05-22 | — | — | WO | claimed |
| WO-2025024500-A1 | METHODS AND SYSTEMS FOR TRANSDERMAL IMMUNOTHERAPY | Passport Technologies, Inc. (US) | 2025-01-30 | — | — | WO | claimed |
| EP-4463555-A1 | GENE EDITING REPORTER SYSTEM AND GUIDE RNA AND COMPOSITION RELATED THERETO; COMPOSITION AND METHOD FOR KNOCKING OUT DNA WITH MORE THAN TWO GRNAS; GENE EDITING IN THE EYE; AND GENE EDITING USING BASE EDITORS | INCISIVE GENETICS, INC. (CA) | 2024-11-20 | — | — | EP | claimed |
| US-20240358652-A1 | LIPID NANOPARTICLE FORMULATIONS | MONASH UNIVERSITY (AU) | 2024-10-31 | — | — | US | claimed |
| EP-4409004-A1 | COMPOSITIONS AND METHODS FOR PREVENTING, AMELIORATING, OR TREATING SICKLE CELL DISEASE | The University of British Columbia (CA) | 2024-08-07 | — | — | EP | claimed |
| EP-4387657-A1 | LIPID NANOPARTICLE FORMULATIONS | Monash University (AU) | 2024-06-26 | — | — | EP | claimed |
| US-20240175012-A1 | GUIDE RNAS AND COMPOSITIONS FOR EDITING HUNTINGTIN GENE, AND METHODS RELATED THERETO | UNIV BRITISH COLUMBIA (CA) | 2024-05-30 | — | — | US | claimed |
| US-20240175024-A1 | DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES | ALNYLAM PHARMACEUTICALS, INC. | 2024-05-30 | — | — | US | claimed |
| EP-4281562-A1 | GUIDE RNAS AND COMPOSITIONS FOR EDITING HUNTINGTIN GENE, AND METHODS RELATED THERETO | The University of British Columbia (CA) | 2023-11-29 | — | — | EP | claimed |
| WO-2017075038-A1 | NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES | RANA THERAPEUTICS, INC. (US) | 2017-05-04 | — | — | WO | claimed |
| US-20160122759-A1 | DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2016-05-05 | — | — | US | claimed |
| EP-2994167-A2 | DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES | Alnylam Pharmaceuticals, Inc. (US) | 2016-03-16 | — | — | EP | claimed |
| WO-2014182661-A2 | DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES | ALNYLAM PHARMACEUTICALS, INC (US) | 2014-11-13 | — | — | WO | claimed |
| US-20100104629-A1 | CATIONIC LIPIDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-04-29 | — | — | US | claimed |
| US-20100099738-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-04-22 | — | — | US | claimed |
| WO-2010030739-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-03-18 | — | — | WO | claimed |
| WO-2010030730-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-03-18 | — | — | WO | claimed |
| US-20100063135-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-03-11 | — | — | US | claimed |
| WO-2009129395-A1 | CATIONIC LIPIDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2009-10-22 | — | — | WO | claimed |